Drug R&D

Analyzing Google’s healthcare growth strategy: Can the tech giant become the sector’s go-to AI provider?

Analyzing Google’s healthcare growth strategy: Can the tech giant become the sector’s go-to AI provider?

We mined Google’s investments and partnerships to discern the company's strategic priorities in healthcare.

Apr 25, 2024

Analyzing Microsoft’s healthcare growth strategy: How the software giant is betting generative AI will transform the sector

Analyzing Microsoft’s healthcare growth strategy: How the software giant is betting generative AI will transform the sector

We mined Microsoft's acquisitions, investments, and partnerships to discern the company's strategic priorities in healthcare.

Apr 19, 2024

Analyzing AstraZeneca’s growth strategy: How the pharma giant is streamlining drug development using AI and real-world data

Analyzing AstraZeneca’s growth strategy: How the pharma giant is streamlining drug development using AI and real-world data

We mined AstraZeneca’s partnerships, investments, and acquisitions to discern the company's strategic priorities.

Apr 3, 2024

How AI-powered simulations are reshaping clinical trials

How AI-powered simulations are reshaping clinical trials

From simulating protocol variations for trial design to predicting relapse rates in patients, we take a look at how AI-powered simulations are improving clinical trial efficiency and success.

Jan 19, 2024

The most aggressive Fortune 500 company is not a tech company

The most aggressive Fortune 500 company is not a tech company

Pharma giant Bristol Myers Squibb's 3 mega-acquisitions cap off a year of heightened big pharma M&A activity.

Jan 16, 2024

The generative AI in healthcare market map

The generative AI in healthcare market map

From protein design to synthetic patient data, we break down the categories of tech vendors bringing generative AI into the research and clinical settings.

Jan 11, 2024

Menopause care funding surged in 2023, but startups in the space face long-term risks

Menopause care funding surged in 2023, but startups in the space face long-term risks

From mental health support features to ovarian health, we look at recent activity in key menopause care markets to identify trends in the space.

Jan 10, 2024

4 applications of generative AI in drug R&D

4 applications of generative AI in drug R&D

From molecule design to biomedical NLP, we break down 4 ways pharmaceutical companies can leverage generative AI — and the companies leading the way.

Jan 8, 2024

Is Nvidia the next big health IT vendor? How the chipmaker is building a healthcare AI ecosystem

Is Nvidia the next big health IT vendor? How the chipmaker is building a healthcare AI ecosystem

We mined Nvidia's investments and partnerships to discern the company’s strategic priorities in healthcare.

Jan 5, 2024

Analyzing Bayer’s healthcare strategy: How the pharma giant is embracing tech to advance patient care

Analyzing Bayer’s healthcare strategy: How the pharma giant is embracing tech to advance patient care

We mined Bayer’s acquisitions, investments, and partnerships to discern the company's strategic priorities.

Nov 1, 2023

The pharma AI market map

The pharma AI market map

Amid soaring interest in AI, this market map breaks down the AI companies helping pharma giants discover new drug targets and carry out clinical trials more efficiently.

Aug 29, 2023

The oncology tech market map

The oncology tech market map

From AI-powered liquid biopsies to clinical decision support, we break down the vendors aiming to transform cancer care, diagnosis, and treatment.

Aug 10, 2023

Pharma AI Readiness Index: Who’s best-positioned for the AI boom?

Pharma AI Readiness Index: Who’s best-positioned for the AI boom?

The Pharma AI Readiness Index assesses how prepared top pharmaceutical companies are to adopt and respond to rapidly evolving AI technologies.

Aug 8, 2023

The clinical trials market map

The clinical trials market map

From EHR-based patient recruitment to decentralized clinical trials, we break down the critical categories of vendors digitizing clinical trials.

Aug 1, 2023

Here’s how much pharma executives are paying for real-world data — and who they’re buying data from

Here’s how much pharma executives are paying for real-world data — and who they’re buying data from

Pharma companies are paying anywhere from $75K to $5M per year to acquire datasets that can speed up drug discovery, clinical trial design, and regulatory reporting.

Jul 10, 2023

AI drug discovery & design startups have raised $10B since 2019

AI drug discovery & design startups have raised $10B since 2019

Despite a slowdown in funding, the space has seen notable acquisitions and partnerships in 2023 involving BioNTech, Eli Lilly, and others. We assess the market's momentum.

Jun 27, 2023

Analyzing Amazon’s healthcare strategy: How the tech giant is going after primary care, therapeutics, and beyond

Analyzing Amazon’s healthcare strategy: How the tech giant is going after primary care, therapeutics, and beyond

We mined Amazon’s acquisitions, investments, and partnerships to discern the company’s strategic priorities in healthcare.

Jun 5, 2023

Y Combinator’s healthcare investment strategy prioritizes drug R&D, care delivery, and insurance

Y Combinator’s healthcare investment strategy prioritizes drug R&D, care delivery, and insurance

Over 20,000 founders applied to Y Combinator's Winter 2023 cohort. We analyze the 20 healthcare companies that made the cut.

May 25, 2023

7 applications of generative AI in healthcare

7 applications of generative AI in healthcare

From drug design to EHR documentation, we break down 7 ways health systems can leverage generative AI — and the vendors building these solutions.

May 9, 2023

7 applications of generative AI in healthcare

7 applications of generative AI in healthcare

From drug design to EHR documentation, we break down 7 ways health systems can leverage generative AI — and the vendors building these solutions.

May 9, 2023

Pfizer’s 2023 partnerships highlight a continued focus on Covid-19 as well as AI and data to speed oncology drug development

Pfizer’s 2023 partnerships highlight a continued focus on Covid-19 as well as AI and data to speed oncology drug development

We mined CB Insights business relationship data on Pfizer to highlight who it’s working with and distill its areas of strategic focus.

May 5, 2023

Is the psychedelics space experiencing a comedown?

Is the psychedelics space experiencing a comedown?

Despite strong tailwinds, psychedelics companies aren’t attracting investors like they used to.

May 3, 2023

Market Trend Report: Knowledge discovery for pharma and CRO leaders

Market Trend Report: Knowledge discovery for pharma and CRO leaders

We outline the market outlook for knowledge discovery in the life sciences industry — from investment trends and leading companies to recommendations for players in the space.

Apr 5, 2023

Market Trend Report: Cloud R&D software for pharma and CRO leaders

Market Trend Report: Cloud R&D software for pharma and CRO leaders

We outline the market outlook for cloud R&D software in the life sciences industry — from investment trends and leading companies to recommendations for players in the space.

Apr 5, 2023

Market Trend Report: Nature mining for pharma and CRO leaders

Market Trend Report: Nature mining for pharma and CRO leaders

We outline the market outlook for nature mining in the life sciences industry — from investment trends and leading companies to recommendations for the players in the space.

Apr 5, 2023

Back More